Lifeline Biotechnologies Stock Price on September 30, 2024
| LLBO Stock | USD 0.0001 0.0003 75.00% |
If you're considering investing in Lifeline Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Lifeline Biotechnologies stands at 0.0001, as last reported on the 23rd of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. Lifeline Biotechnologies is out of control given 3 months investment horizon. Lifeline Biotechnologies has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. We have analyzed twenty-seven different technical indicators, which can help you to evaluate if expected returns of 10.41% are justified by taking the suggested risk. Use Lifeline Biotechnologies Mean Deviation of 33.26, downside deviation of 63.22, and Risk Adjusted Performance of 0.1373 to evaluate company specific risk that cannot be diversified away.
Lifeline Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Lifeline |
Sharpe Ratio = 0.1621
| Best Portfolio | Best Equity | LLBO | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 64.23 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Lifeline Biotechnologies is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lifeline Biotechnologies by adding it to a well-diversified portfolio.
Lifeline Biotechnologies Valuation on September 30, 2024
It is possible to determine the worth of Lifeline Biotechnologies on a given historical date. On September 30, 2024 Lifeline was worth 4.0E-4 at the beginning of the trading date compared to the closed value of 4.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lifeline Biotechnologies pink sheet. Still, in general, we apply an absolute valuation method to find Lifeline Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lifeline Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lifeline Biotechnologies' related companies.
| Open | High | Low | Close | Volume | |
| 0.0004 | 0.0004 | 0.0004 | 0.0004 | 1.00 | |
09/30/2024 | 0.0004 | 0.0004 | 0.0004 | 0.0004 | 1.00 |
| 0.0004 | 0.0004 | 0.0004 | 0.0004 | 1.00 |
| Backtest Lifeline Biotechnologies | | | Lifeline Biotechnologies History | | | Lifeline Biotechnologies Valuation | Previous | Next |
Lifeline Biotechnologies Trading Date Momentum on September 30, 2024
| On October 01 2024 Lifeline Biotechnologies was traded for 0.0004 at the closing time. The top price for the day was 0.0004 and the lowest listed price was 0.0004 . There was no trading activity during the period 1.0. Lack of trading volume on October 1, 2024 did not cause price change. The trading delta at closing time against the current closing price is 50.00% . |
Lifeline Biotechnologies Fundamentals Correlations and Trends
By evaluating Lifeline Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lifeline Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lifeline financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lifeline Biotechnologies Pink Sheet history
Lifeline Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lifeline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lifeline Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lifeline Biotechnologies stock prices may prove useful in developing a viable investing in Lifeline Biotechnologies
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada. Lifeline Biotech operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Lifeline Biotechnologies Pink Sheet Technical Analysis
Lifeline Biotechnologies technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Lifeline Biotechnologies Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Lifeline Biotechnologies cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lifeline Biotechnologies December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Lifeline Biotechnologies pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lifeline Biotechnologies shares will generate the highest return on investment. By undertsting and applying Lifeline Biotechnologies pink sheet market strength indicators, traders can identify Lifeline Biotechnologies entry and exit signals to maximize returns
Lifeline Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lifeline Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Lifeline Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lifeline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1373 | |||
| Jensen Alpha | 10.29 | |||
| Total Risk Alpha | 8.46 | |||
| Sortino Ratio | 0.1617 | |||
| Treynor Ratio | (5.47) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.